Current stage-Stage II (Early) Posts on Medivizor
Navigation Menu

Current stage-Stage II (Early) Posts on Medivizor

Does radiotherapy improve outcomes for patients with primary breast diffuse large B-cell lymphoma?

Posted by on Jul 10, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the impact of radiotherapy on the outcomes of rituximab (Rituxan)-treated patients with primary breast diffuse large B-cell lymphoma. This study concluded that radiotherapy has significant therapeutic benefits for these patients. Some background Primary breast diffuse large B-cell lymphoma (DLBCL) is a rare type of...

Read More

Comparing obinutuzumab and rituximab in first-line chemotherapy regimens for follicular lymphoma

Posted by on Jul 2, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the safety and effectiveness of obinutuzumab (Gazyva) versus rituximab (Rituxan) plus chemotherapy for previously untreated follicular lymphoma. This study concluded that obinutuzumab improved survival outcomes compared to rituximab. Some background Follicular lymphoma is the most common type of...

Read More

What are the outcomes for advanced HL patients receiving intensified BEACOPP chemotherapy after ABVD chemotherapy?

Posted by on Feb 9, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the outcomes of advanced-stage classical Hodgkin’s lymphoma (HL) patients treated with ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy followed by escalated (higher dose) BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) chemotherapy...

Read More

Treatment options for elderly patients with early stage Hodgkin lymphoma

Posted by on Nov 6, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reviewed the treatments for elderly patients with early-stage Hodgkin lymphoma. The study concluded that combined chemotherapy and radiation therapy has the best outcomes, however the use of radiation therapy is not ideal. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, outcomes in...

Read More

Different types of treatment for patients with early stage mantle cell lymphoma

Posted by on Oct 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the outcomes of different types of initial treatment for patients diagnosed with early stage mantle cell lymphoma. The study concluded that a reduced intensity treatment approach is worthwhile for patients with early stage mantle cell lymphoma. Some background Mantle cell lymphoma (MCL) is a type of non-Hodgkin...

Read More

A review of chemotherapy alone or chemotherapy plus radiation therapy to treat adult patients with Hodgkin lymphoma

Posted by on Sep 26, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This paper is a review of the effectiveness of chemotherapy alone or chemotherapy plus radiotherapy for treating adult patients with early stage Hodgkin lymphoma. The review concluded that, for the same chemotherapy regimen, RT may increase progression free survival, but has little effect on overall survival for patients. Some background...

Read More

What is the most effective chemotherapy combination for advanced follicular lymphoma?

Posted by on May 30, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared different chemotherapy regimens and rituximab (Rituxan) for the initial treatment of advanced follicular lymphoma. This study concluded that the combinations R-CHOP and R-FM were more effective than R-CVP. R-CHOP was associated with fewer severe side effects than R-FM. Some background Follicular lymphoma (FL) is...

Read More

What is the role of combined chemotherapy and radiation in early-stage Hodgkin lymphoma?

Posted by on Mar 11, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study explored whether radiation therapy was necessary in patients with early-stage Hodgkin lymphoma. The study concluded that disease progression occurred more often in patients who did not undergo radiation. Some background The standard treatment option for early stage Hodgkin lymphoma is chemotherapy followed by radiation....

Read More

What pediatric Hodgkin lymphoma patients benefit from radiation after chemotherapy?

Posted by on Jan 3, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This trial examined which children with Hodgkin lymphoma benefit from radiation therapy after chemotherapy. The authors concluded that patients with a combination of bulky disease (tumors larger than 6 cm) and anemia (low levels of red blood cells) benefited most. Some background Hodgkin lymphoma is a cancer of the lymph...

Read More

Treatment options for early-stage Hodgkin lymphoma

Posted by on Dec 24, 2016 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reviewed the treatment options for early-stage Hodgkin lymphoma. Some background Early-stage Hodgkin lymphoma refers to stages I and II. Early-stage can be further divided into favorable or unfavorable. Patients with unfavorable disease may present with certain risk factors. These include large chest tumors, inflammation...

Read More

All hands on deck: leaving out chemotherapies from the ABVD regimen can decrease effectiveness

Posted by on Dec 20, 2016 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined whether the number of chemotherapy agents in the combination ABVD could be reduced when treating Hodgkin lymphoma. The authors concluded that to be effective all four chemotherapies need to be included. Some background More than 80% of patients with early-stage, favorable Hodgkin lymphoma experience long-term...

Read More